Loading
CH
Changchun High-Tech Industry (Group) Co., Ltd. Stock: price and insider trades · China
长春高新
No insider purchase over the last 90 days. The latest was filed 16 Aug 2024.
Changchun High-Tech Industry (Group) Co., Ltd.: what insiders have been doing
This page follows insider dealings at Changchun High-Tech Industry (Group) Co., Ltd. as filed with SSE / SZSE (CSRC), a company from the Health Care sector based in People's Republic of China. Nothing new has been filed by managers of Changchun High-Tech Industry (Group) Co., Ltd. in twelve months, the latest record being from 16 August 2024.
The full history, which starts in 2021, counts 19 purchases against no sales.
For comparison within the same sector, see the insider buying recorded at MAIA Biotechnology, Inc. and Cooper Companies, Inc. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Key facts
Headquarters: People's Republic of China
Source: Wikidata (CC0).
Insider Decl.
19
Thresholds
n/a
Buy Volume
€4M
19 ops. · all time
Sell Volume
n/a
n/a
Since the insiders bought
- +22.3%Entry CN¥84.19 · Close at T+365 CN¥102.99
- +22.3%Entry CN¥84.19 · Close at T+365 CN¥102.99
- +22.3%Entry CN¥84.19 · Close at T+365 CN¥102.99
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 18,205 of 24,148 companies
34.4
score / 100
Value21
Quality48
FCF yld-4.8%
Earn yld0.5%
EV/EBITDA38.8x
ROE-2.0%
Gross mgn82%
Net mgn1.3%
Debt/EBITDA2.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CN¥71.83
Analyst consensus
1 analysts1.00/5
CN¥102.77Target CN¥102.77(+43%)CN¥102.77
Income statement
RevenueCN¥12.1B
Gross profitCN¥9.9B82% margin
EBITDACN¥804.5M7% margin
Net incomeCN¥155M-3.2% margin
Valuation
P/Book1.3x
Beta0.34
Balance sheet & cash
Market capCN¥29.3B
Total debtCN¥1.9B
Free Cash Flow-CN¥1.4B
Debt / Equity9%
Profitability & ownership
ROE-2.0%
ROA0.5%
% insiders29.2%
% institutions7.7%
Last declaration on 16 August 2024
Declarations19 total
19 of 19 declarations
About Changchun High-Tech Industry (Group) Co., Ltd.
长春高新 is a company specializing in the healthcare and pharmaceutical sector. It is listed on the XSHE market.
